toggle visibility Search & Display Options

Select All    Deselect All
 | 
Citations
 | 
   print
Guerrero, P. A., Tchaicha, J. H., Chen, Z., Morales, J. E., McCarty, N., Wang, Q., et al. (2017). Glioblastoma stem cells exploit the alphavbeta8 integrin-TGFbeta1 signaling axis to drive tumor initiation and progression. Oncogene, .
toggle visibility
Magrath, J. W., & Kim, Y. (2017). Salinomycin's potential to eliminate glioblastoma stem cells and treat glioblastoma multiforme (Review). Int J Oncol, 51(3), 753–759.
toggle visibility
Miranda, A., Blanco-Prieto, M., Sousa, J., Pais, A., & Vitorino, C. (2017). Breaching barriers in glioblastoma. Part I: Molecular pathways and novel treatment approaches. Int J Pharm, 531(1), 372–388.
toggle visibility
Yin, J., Oh, Y. T., Kim, J. - Y., Kim, S. S., Choi, E., Kim, T. H., et al. (2017). Transglutaminase 2 Inhibition Reverses Mesenchymal Transdifferentiation of Glioma Stem Cells by Regulating C/EBPbeta Signaling. Cancer Res, 77(18), 4973–4984.
toggle visibility
Behling, F., Kaltenstadler, M., Noell, S., Schittenhelm, J., Bender, B., Eckert, F., et al. (2017). The Prognostic Impact of Ventricular Opening in Glioblastoma Surgery: A Retrospective Single Center Analysis. World Neurosurg, 106, 615–624.
toggle visibility
Select All    Deselect All
 | 
Citations
 | 
   print